Skip to main content
    M

    Microbot Medical Inc (MBOT)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $0.69
    +0.04 (+6.92%)

    Market Cap: $65.73M

    Last updated: Nov 17, 2026 at 4:43 PM ET

    Microbot Medical Inc (MBOT) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Microbot Medical (MBOT) has a market cap of $65.73M and an enterprise value of $62.58M. It kept -4722.25% of revenue as net income over the last 12 months. Its share count is up 84.07% from a year earlier.

    Total Valuation

    Enterprise value is 4.80% below the market cap, as cash exceeds debt.

    Market Cap$65.73M
    Enterprise Value$62.58M
    Latest price (Nov 17, 2026)$0.69

    Key Dates

    The next earnings report is expected on Mar 24, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 24, 2027 (expected)
    Last Earnings DateNov 13, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.01% in the quarter ended Jun 30, 2026 and grew 112.69% a year over 2 years.

    Shares Outstanding67.16M
    Shares Change (YoY)+84.07%
    Shares Change (QoQ)+0.01%
    Share Count Growth (2Y CAGR)+112.69%

    Valuation Ratios

    Sales and book value multiples are 133.7x and 0.7x.

    P/S Ratio133.7x
    Forward P/S51.6x
    P/B Ratio0.7x

    Price Statistics

    The stock is down 66.72% over 52 weeks and trades 38.94% below its 50-day average.

    Beta (1Y)2.00
    52-Week Change-66.72%
    1-Month Change-27.69%
    3-Month Change-55.55%
    6-Month Change-60.17%
    5-Year Change-84.92%
    10-Year Change-90.67%
    Total Return (1Y)-66.71%
    Total Return (3Y CAGR)-20.66%
    Total Return (5Y CAGR)-34.96%
    Max Drawdown (1Y)-77.39%
    Max Drawdown (3Y)-85.68%
    Sharpe Ratio (1Y)-1.34
    Correlation with SPY (1Y)0.35
    50-Day Average$1.13
    200-Day Average$1.79
    52-Week Range$0.52 to $2.85
    RSI (14 Days)28.8
    Average Volume (20 Days)1.46M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 18.56x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio18.56x
    Quick Ratio17.82x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -23.70% and return on assets is -22.27% over the last 12 months.

    Return on Equity (ROE)-23.70%
    Return on Assets (ROA)-22.27%
    Asset Turnover0.01x
    Inventory Turnover0.38x
    Receivables Turnover2.46x
    Cash Conversion Cycle741 days

    Scores

    MBOT has an Altman Z-Score of 4.38, in the safe zone above 2.99, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score4.38
    Altman Z ZoneSafe
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $346.00K over the last 12 months is up 311.90% from the 12 months before.

    Revenue$346.00K
    Revenue Growth (YoY)+311.90%
    Gross Profit-$651.00K
    Operating Income-$18.51M
    Pretax Income-$16.34M
    Net Income-$16.34M
    Reported EPS (TTM)-$0.26

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 93.96% of the $73.36M in total assets.

    Cash and Equivalents$3.15M
    Total Debt$0
    Net Cash$3.15M
    Net Cash Per Share$0.05
    Working Capital$68.28M
    Shareholder Equity$68.93M
    Book Value Per Share$1.03
    Total Assets$73.36M
    Total Liabilities$4.44M

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    After $288.00K of capital spending, operating cash flow left -$17.93M of free cash flow.

    Operating Cash Flow-$17.64M
    Capital Expenditures$288.00K
    Free Cash Flow-$17.93M
    FCF Per Share-$0.27
    Depreciation and Amortization$47.00K

    Trailing 12 months through Jun 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -5348.84%.

    Gross Margin-188.15%
    Operating Margin-5348.84%
    Pretax Margin-4722.25%
    Net Margin-4722.25%
    FCF Margin-5181.79%

    Growth

    Book Value Per Share Growth (2Y CAGR)+76.40%
    Tangible Book Per Share Growth (2Y CAGR)+76.40%

    Revenue and profit by year

    Dividends and Yields

    MBOT does not pay a dividend. Its free cash flow yield is -38.74%.

    FCF Yield-38.74%
    Buyback Yield-116.04%
    Shareholder Yield-116.04%

    Stock Splits

    The last split was a 1-for-15 reverse split on Sep 5, 2018.

    Last Split DateSep 5, 2018
    Split TypeReverse split
    Split Ratio1:15

    Peer Position

    Against 12 similar companies, MBOT has the 2nd highest P/S.

    P/S Ratio133.7x vs 1.0x median
    Revenue Growth (Trailing 4 Quarters, YoY)+311.90% vs +9.27% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About MBOT

    What is MBOT's market cap?

    Microbot Medical has a market cap of $65.73M. Its enterprise value, which adds debt and subtracts cash, is $62.58M.

    How many shares of MBOT are outstanding?

    Microbot Medical has 67.16M shares outstanding. The count is up 84.07% from a year earlier.

    Does MBOT pay a dividend?

    No. Microbot Medical does not pay a dividend.

    How much debt does MBOT have?

    Microbot Medical has $0 of total debt and $3.15M of cash and equivalents, a net cash position of $3.15M.